Growing blood vessels are experts at multitasking. Not only do cells in their walls divide, they must also sprout in new directions while learning to specialize, ultimately becoming part of vein, artery or lymphatic vessels. ...
Oct 5, 2021
0
17
Scientists have identified two subtypes of metastatic prostate cancer that respond differently to treatment, information that could one day guide physicians in treating patients with the therapies best suited to their disease.
Sep 23, 2021
0
9
For breast cancer patients, standard-of care therapies become drastically less effective if their tumor has spread to other parts of the body, such as the lung.
Sep 17, 2021
0
68
A Phase 2 trial led by City of Hope, a world-renowned research and treatment center for cancer and diabetes, suggests that adding the novel ataxia telangiectasia and Rad3-related (ATR) inhibitor drug berzosertib to standard-of-care ...
Aug 26, 2021
0
48
Researchers are bringing the use of acoustic waves to target and destroy cancerous tumours closer to reality.
Aug 24, 2021
0
44
The COVID-19 vaccines currently authorized by the Federal Drug Administration have proved to be far more effective than the wildest dreams of public health officials early in the pandemic. But Sidi Bencherif thinks we could ...
Aug 13, 2021
1
1
Women who develop heart failure following certain breast cancer treatments are generally healthier and have a better prognosis than those with heart failure from other causes, a new study finds.
Jul 1, 2021
0
1
The National Comprehensive Cancer Network (NCCN) announced today the publication of new NCCN Guidelines for Patients: Anemia and Neutropenia, Low Red and White Blood Cell Counts funded by the NCCN Foundation and endorsed ...
May 3, 2021
0
2
The hormonal therapies used to treat many breast and prostate cancers raise the risk of a heart attack and stroke, and patients should be monitored regularly and receive treatment to reduce risk and detect problems as they ...
Apr 26, 2021
0
10
A single dose of a COVID-19 vaccine triggers an immune response in around 70% of patients with myeloma—suggesting that it does provide protection against the virus.
Apr 20, 2021
0
16
